Terms ending in 2034
Every in-force patent on Araxes Pharma LLC's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,227,978 | Covalent Inhibitors of Kras G12C In force · High confidence | Araxes Pharma LLC | In force | High confidence | |
| US 9,926,267 | Covalent Inhibitors of Kras G12C In force · High confidence | Araxes Pharma LLC | In force | High confidence | |
| US 10,273,207 | Covalent Inhibitors of Kras G12C In force · High confidence | Araxes Pharma LLC | In force | High confidence | |
| US 10,882,847 | Inhibitors of Kras G12C Mutant Proteins In force · High confidence | Araxes Pharma LLC | In force | High confidence | |
| US RE50,527 | Covalent Inhibitors of Kras G12C In force · Low confidence | Araxes Pharma LLC | In force | Low confidence | |
| US 9,840,516 | Substituted Quinazolines as Inhibitors of Kras G12C In force · High confidence | Araxes Pharma LLC | In force | High confidence | |
| US 10,111,874 | Combination Therapies for Treatment of Cancer In force · High confidence | Araxes Pharma LLC | In force | High confidence | |
| US 10,144,724 | Substituted Quinazoline Compounds and Methods of Use Thereof In force · High confidence | Araxes Pharma LLC | In force | High confidence | |
| US 10,351,550 | Substituted Quinazoline Compounds and Methods of Use Thereof In force · High confidence | Araxes Pharma LLC | In force | High confidence | |
| US 10,370,386 | Substituted Quinolines as Inhibitors of Kras G12C In force · High confidence | Araxes Pharma LLC | In force | High confidence | |
| 3 more term ends in 2034 · Pro | |||||
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.